Abstract
Background and Aims : EAS/ESC and Canadian Cardiovascular Society (CCS) Guidelines recommend that everyone should have a determination of Lp(a) level once in a lifetime. 20% of the population will be found to have elevated Lp(a) above 50mg/dL (125nmoles/L) {high Lp(a)}. High Lp(a) produces significant risk of ASCVD particularly CAD. The majority of high Lp(a) patients will not have established ASCVD but need recommendations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
